Michael John Kazley serves as Executive at NovaBay Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Michael John Kazley has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 21, 2025 involved exercising options for 56,806,080 shares valued at $0.
Michael John Kazley currently holds 56,806,080 shares of NovaBay Pharmaceuticals, Inc. (NBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael John Kazley has been a net neutral trader of NBY stock. They have purchased $0 and sold $0 worth of shares.
Michael John Kazley's most recent insider trade was on Oct 21, 2025, when they sold 56,806,080 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |